TONIC-CLONIC SEIZURES

Clinical trials for TONIC-CLONIC SEIZURES explained in plain language.

Never miss a new study

Get alerted when new TONIC-CLONIC SEIZURES trials appear

Sign up with your email to follow new studies for TONIC-CLONIC SEIZURES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Epilepsy patients get chance for 3-Year drug trial

Disease control ENROLLING_BY_INVITATION

This study aims to learn about the long-term safety and effectiveness of the drug XEN1101 for controlling seizures. It is open to about 880 people with focal epilepsy or tonic-clonic seizures who have already completed a previous related study. Participants will take the drug dai…

Matched conditions: TONIC-CLONIC SEIZURES

Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control

Last updated Mar 17, 2026 12:55 UTC

TONIC-CLONIC SEIZURES

Get alerted when new TONIC-CLONIC SEIZURES trials appear

Epilepsy patients get chance for 3-Year drug trial